Open Trade
AMTILong Stock
Entry comments: Entry price is an average of multiple stupid buys of this tanking stock. Down 57% on the day. Stocktitan categorized the news from this biotech's clinical trial as very positive but if you read the article it is actually bad news. Should have been more careful.
Broker:ETrade
| Date | Price | |
|---|---|---|
| Entry | 12/23/2022 | 0.74649 |
- Total Views31
- Position Size350
Copy and paste the following into your page or blog. If using WordPress, you must paste this in the HTML tab only:
